Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$336K Sell
9,356
-91,954
-91% -$3.35M ﹤0.01% 521
2016
Q2
$3.65M Sell
101,310
-4,400
-4% -$150K 0.04% 212
2016
Q1
$3.34M Buy
105,710
+77,554
+275% +$2.3M 0.04% 242
2015
Q4
$843K Buy
+28,156
New +$876K 0.01% 425
2015
Q2
Sell
-38,578
Closed -$1.24M 561
2015
Q1
$1.24M Buy
+38,578
New +$1.18M 0.02% 337
2014
Q4
Sell
-52,094
Closed -$1.52M 532
2014
Q3
$1.52M Sell
52,094
-46,070
-47% -$1.4M 0.02% 302
2014
Q2
$3.06M Buy
+98,164
New +$3.06M 0.05% 207
2013
Q4
Sell
-346,744
Closed -$10.7M 493
2013
Q3
$10.7M Buy
346,744
+260,124
+300% +$7.83M 0.17% 140
2013
Q2
$2.52M Buy
+86,620
New +$2.35M 0.04% 249

Other funds holding AFL

Analytic Investors's AFL Position: Q3 2016 in Review

Analytic Investors reduced its Aflac (AFL) stake by 91% in Q3 2016, selling an estimated $3.35M and leaving 9,356 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #521.

Analytic Investors first reported a position in AFL in Q2 2013 and has held it in 9 quarters since. The position peaked at $10.7M in Q3 2013. 905 funds tracked by Wall St. Rank hold AFL as of Q3 2016.

  • Analytic Investors held 9,356 shares of Aflac worth $336K as of Q3 2016.
  • Analytic Investors sold 91,954 Aflac shares in Q3 2016, an estimated $3.35M.
  • Aflac made up ﹤0.01% of Analytic Investors's portfolio in Q3 2016, its #521 holding.
  • Analytic Investors first reported a position in Aflac in Q2 2013 and has held it in 9 quarters since.
  • Analytic Investors's Aflac position peaked at $10.7M in Q3 2013.
  • 905 funds tracked by Wall St. Rank held Aflac as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.